Robert Venes
The Northern European private equity firm and founder Investor AB have had a Skr38bn offer for Gambro accepted by the listed Swedish medical technology company’s board.
India’s Ranbaxy Laboratories, unsuccessful in its bid for 3i’s German pharma business betapharm in February, has paid $324m for Advent International-backed Terapia.
The global private equity firm has unveiled total realisations of £1.82bn in its pre-close announcement.
The French cable operator acquired by London-based investor Cinven last year is set to purchase UPC France from Liberty Global for approximately €1.2bn.
Boston- and Munich-based venture capital firm TVM Capital has named three partners in its German office.
The former London MD of AXA Private Equity’s fund of funds arm is understood to be joining the US-based firm to launch a European co-investment fund.
London-based private equity firm Exponent Private Equity has made its second investment with the purchase of Durrants Media Monitoring.
The London-based mid-market investor has sold equipment supplier Hydrex to Quilvest and the Shoaibi Group for £106m.
The private equity arm of the French insurer has announced the departure of three senior figures in its London and New York funds of funds teams, as well as a listing for the UK business.
Just six Israeli venture capital funds accounted for the bulk of fundraising last year, amid increasing appetite from foreign pension funds.